Earnings Feed
Start Free
Home/Filings/4/0001144204-13-025804
4//SEC Filing

GASPARINI ROBERT P 4

Accession 0001144204-13-025804

CIK 0001077183other
View on SEC.govCompany Profile

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 9:23 PM ET

Size

15.5 KB

Accession

0001144204-13-025804

Insider Transaction Report

Form 4
Period: 2013-04-29
NEOGENOMICS INCNEO
GASPARINI ROBERT P
DirectorChief Science Officer
Transactions
  • Sale

    Common Stock

    2013-04-29$3.80/sh−25,000$95,000→ 25,000 total
  • Award

    Common Stock

    2013-04-29$0.25/sh+50,000$12,500→ 50,000 total
  • Sale

    Common Stock

    2013-04-30$3.75/sh−5,000$18,750→ 20,000 total
  • Sale

    Common Stock

    2013-05-01$3.56/sh−7,500$26,700→ 12,500 total
  • Exercise of In-Money

    Stock Option (right to buy)

    2013-04-29+50,000→ 525,000 total
    Exercise: $0.25From: 2005-01-03Exp: 2015-01-03→ Common Stock (0 underlying)
Holdings

  • Stock Option (right to buy)

    Exercise: $0.80From: 2008-03-12Exp: 2015-03-12→ Common Stock (0 underlying)
    584,000

  • Stock Option (right to buy)

    Exercise: $1.47From: 2007-02-13Exp: 2017-02-12→ Common Stock (0 underlying)
    100,000

  • Stock Option (right to buy)

    Exercise: $0.62From: 2009-12-31Exp: 2016-02-01→ Common Stock (0 underlying)
    150,000
Footnotes (2)
  • [F1]On March 12, 2008 Mr. Gasparini was granted an option to purchase 784,000 shares. The first vesting and exercisable date was March 12, 2008. On this date 24,000 options vested and then there was to be 45 additional monthly vesting of 8,000 shares for a total of 384,000 options. Included in this grant were 400,000 non-qualified options with an initial vesting on March 12, 2008. From this grant 200,000 options were cancelled. In terms of the remaining 200,000 non-qualified options, 100,000 options are vested and exercisable.
  • [F2]On February 2, 2009 Mr. Gasparini was granted an option to purchase 200,000 shares. These were performance options which vest based on various milestones. To date 50,000 shares are vested and exercisable, 50,000 shares have been cancelled and 100,000 shares are unvested.

Documents

1 file

Issuer

NEOGENOMICS INC

CIK 0001077183

→
Entity typeother

Related Parties

1
  • filerCIK 0001518647

Filing Metadata

Form type
4
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 9:23 PM ET
Size
15.5 KB
View on SEC.gov